Drugs / GX-70
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03159975 | Mar → Aug 2018 | pulmonary tuberculosis | Yonsei University | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GX-70 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03159975 ↗ |
| Modality | Vaccine | “a DNA-based Therapeutic Vaccine” NCT03159975 ↗ |
| Route | Intramuscular | “Administered Intramuscularly by Electroporation (EP)” NCT03159975 ↗ |